2026 Q3 Portfolio Activity
In 2026 Q3, Sarissa Capital Management LP maintained a portfolio of 10 distinct positions. The fund also reduced its exposure to AMARIN CORP PLC by 23.1%.
Position History
hover any row below to update
Loading…
Total Positions
10
Quarter
2026 Q3
Top Holding
INVA (26.2%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-10 of 10
Sarissa Capital Management LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
INVA
INNOVIVA INC
|
Healthcare | 26.18% | 24.14% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
1,890,604 | $40,099,711 |
$12.89
+41.9%
|
2016 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
IRWD
IRONWOOD PHARMA...
|
Healthcare | 23.82% | 21.75% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
9,188,635 | $36,478,881 |
$10.77
-54.8%
|
2017 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
AMRN
AMARIN CORP PLC
|
Healthcare | 10.92% | 15.00% |
#3
Prev: #3
|
5.0 |
—
|
-386,305 | -23.1% |
P
S
|
1,287,090 | $16,732,170 |
$50.94
-77.9%
|
2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 10.85% | 10.41% |
#4
2
Prev: #6
|
5.5 |
—
|
no change | no change |
P
S
|
166,919 | $16,613,448 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 10.79% | 11.04% |
#5
1
Prev: #4
|
5.5 |
—
|
no change | no change |
P
S
|
116,533 | $16,529,041 | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 9.84% | 10.95% |
#6
1
Prev: #5
|
4.9 |
—
|
no change | no change |
P
S
|
228,623 | $15,068,542 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 5.08% | 4.87% |
#7
Prev: #7
|
3.0 |
—
|
no change | no change |
P
S
|
582,312 | $7,773,865 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 2.07% | 1.47% |
#8
Prev: #8
|
1.8 |
—
|
no change | no change |
P
S
|
4,190 | $3,177,151 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.32% | 0.26% |
#9
Prev: #9
|
1.1 |
—
|
no change | no change |
P
S
|
25,399 | $484,613 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 0.14% | 0.12% |
#10
Prev: #10
|
1.1 |
—
|
no change | no change |
P
S
|
950 | $214,586 | 2015 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-10 of 10 holdings